{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T11:38:47Z","timestamp":1742384327402,"version":"3.37.3"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T00:00:00Z","timestamp":1728950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["874700"],"award-info":[{"award-number":["874700"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jctejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical & Translational Endocrinology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jcte.2024.100372","type":"journal-article","created":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T06:16:11Z","timestamp":1729145771000},"page":"100372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The bio-artificial pancreas to treat type 1 diabetes: Perspectives from healthcare professionals in the Netherlands"],"prefix":"10.1016","volume":"38","author":[{"given":"Dide","family":"de Jongh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eline","family":"Bunnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behiye","family":"Ozcan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Zietse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Massey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcte.2024.100372_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.lpm.2022.104139","article-title":"From islet of Langerhans transplantation to the bioartificial pancreas","volume":"51","author":"Berney","year":"2022","journal-title":"Presse Medicale"},{"key":"10.1016\/j.jcte.2024.100372_b0010","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/tri.13721","article-title":"Generation of insulin-secreting organoids: a step toward engineering and transplanting the bioartificial pancreas","volume":"33","author":"Wassmer","year":"2020","journal-title":"Transpl Int"},{"key":"10.1016\/j.jcte.2024.100372_b0015","doi-asserted-by":"crossref","first-page":"114","DOI":"10.5204\/lthj.3118","article-title":"Regulatory challenges at the intersection of cellular and medical device therapies in Europe: the case of the bioartificial pancreas","volume":"5","author":"Cronin","year":"2023","journal-title":"Law Technol Humans"},{"key":"10.1016\/j.jcte.2024.100372_b0020","unstructured":"Study Details | A Safety, Tolerability, and Efficacy Study of VX-264 in Participants With Type 1 Diabetes | ClinicalTrials.gov n.d. https:\/\/clinicaltrials.gov\/study\/NCT05791201?cond=Diabetes%20Mellitus%20Type%201&intr=VX-264&rank=1 (accessed December 4, 2023)."},{"key":"10.1016\/j.jcte.2024.100372_b0025","unstructured":"Study Details | A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes | ClinicalTrials.gov n.d. https:\/\/clinicaltrials.gov\/study\/NCT04786262?cond=Diabetes%20Mellitus%20Type%201&intr=VX%20880&rank=1 (accessed December 4, 2023)."},{"key":"10.1016\/j.jcte.2024.100372_b0030","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15219","article-title":"The psychosocial burdens of living with diabetes","volume":"41","author":"Kelly","year":"2024","journal-title":"Diabet Med"},{"key":"10.1016\/j.jcte.2024.100372_b0035","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/0145721717697244","article-title":"Expectations and attitudes of individuals with type 1 diabetes after using a hybrid closed loop system","volume":"43","author":"Iturralde","year":"2017","journal-title":"Diabetes Educ"},{"key":"10.1016\/j.jcte.2024.100372_b0040","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/dme.13567","article-title":"Invited Review Psychosocial impacts of hybrid closed-loop systems in the management of diabetes: a review","volume":"35","author":"Farrington","year":"2018","journal-title":"Diabet Med"},{"key":"10.1016\/j.jcte.2024.100372_b0045","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/dme.14252","article-title":"Health professionals\u2019 views about who would benefit from using a closed-loop system: a qualitative study","volume":"37","author":"Lawton","year":"2020","journal-title":"Diabet Med"},{"key":"10.1016\/j.jcte.2024.100372_b0050","doi-asserted-by":"crossref","first-page":"e1711","DOI":"10.1097\/TXD.0000000000001711","article-title":"Clinical translation and implementation of a bio-artificial pancreas therapy: a qualitative study exploring the perspectives of people with type 1 diabetes","volume":"10","author":"de Jongh","year":"2024","journal-title":"Transplant. Direct"},{"key":"10.1016\/j.jcte.2024.100372_b0055","doi-asserted-by":"crossref","first-page":"14906","DOI":"10.1111\/dme.14906","article-title":"The impact of socio-economic deprivation on access to diabetes technology in adults with type 1 diabetes","volume":"39","author":"Fallon","year":"2022","journal-title":"Diabet Med"},{"key":"10.1016\/j.jcte.2024.100372_b0060","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/dme.13333","article-title":"Factors influencing attendance at structured education for Type 1 diabetes in south London","volume":"34","author":"Harris","year":"2017","journal-title":"Diabet Med"},{"key":"10.1016\/j.jcte.2024.100372_b0065","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S2213-8587(17)30411-4","article-title":"Access to diabetes technology: the role of clinician attitudes","volume":"6","author":"Farrington","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jcte.2024.100372_b0070","first-page":"339","article-title":"Barriers to Uptake of Insulin Technologies and Novel Solutions","volume":"14","author":"Pauley","year":"2021","journal-title":"Med Devices (Auckl)"},{"key":"10.1016\/j.jcte.2024.100372_b0075","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1089\/dia.2017.0096","article-title":"Continuous glucose monitoring and global reimbursement: An update","volume":"19","author":"Graham","year":"2017","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jcte.2024.100372_b0080","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1136\/bmjdrc-2021-002537","article-title":"Diabetes technologies for children and adolescents with type 1 diabetes are highly dependent on coverage and reimbursement: results from a worldwide survey","volume":"9","author":"Dos Santos","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.jcte.2024.100372_b0085","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1007\/s13300-021-01160-5","article-title":"Hybrid closed-loop systems for the treatment of type 1 diabetes: a collaborative, expert group position statement for clinical use in central and Eastern Europe","volume":"12","author":"Janez","year":"2021","journal-title":"Diabetes Therapy"},{"key":"10.1016\/j.jcte.2024.100372_b0090","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1177\/193229681000400322","article-title":"Strategies to increase adherence through diabetes technology","volume":"4","author":"Gabbay","year":"2010","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.jcte.2024.100372_b0095","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1089\/dia.2009.0080","article-title":"Attitudes towards insulin pump therapy among adolescents and young people","volume":"12","author":"Seereiner","year":"2010","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jcte.2024.100372_b0100","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1089\/dia.2019.0466","article-title":"What training, support, and resourcing do health professionals need to support people using a closed-loop system? A qualitative interview study with health professionals involved in the closed loop from onset in type 1 diabetes (CLOuD) Trial","volume":"22","author":"Kimbell","year":"2020","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jcte.2024.100372_b0105","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/dme.12879","article-title":"Who gains clinical benefit from using insulin pump therapy? A qualitative study of the perceptions and views of health professionals involved in the Relative Effectiveness of Pumps over MDI and Structured Education (REPOSE) trial","volume":"33","author":"Lawton","year":"2016","journal-title":"Diabet Med"},{"key":"10.1016\/j.jcte.2024.100372_b0110","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/dme.14235","article-title":"A qualitative study of clinician attitudes towards closed-loop systems in mainstream diabetes care in England","volume":"37","author":"Farrington","year":"2020","journal-title":"Diabet Med"},{"key":"10.1016\/j.jcte.2024.100372_b0115","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2337\/dc16-1536","article-title":"Diabetes device use in adults with type 1 diabetes: Barriers to uptake and potential intervention targets","volume":"40","author":"Tanenbaum","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcte.2024.100372_b0120","article-title":"Insulin pump therapy guidelines for successful outcomes","volume":"35","author":"Scheiner","year":"2009","journal-title":"Diab Educat"},{"key":"10.1016\/j.jcte.2024.100372_b0125","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1177\/1932296816660326","article-title":"Diabetes educators: Perceived experiences, supports and barriers to use of common diabetes-related technologies","volume":"10","author":"James","year":"2016","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.jcte.2024.100372_b0130","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1177\/1932296816688010","article-title":"Optimal use of diabetes devices: clinician perspectives on barriers and adherence to device use","volume":"11","author":"Tanenbaum","year":"2017","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.jcte.2024.100372_b0135","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","year":"2007","journal-title":"Int J Qual Health Care"},{"volume":"vol. 6","year":"2017","author":"Glaser","key":"10.1016\/j.jcte.2024.100372_b0140"},{"key":"10.1016\/j.jcte.2024.100372_b0145","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.diabres.2016.08.021","article-title":"Type 1 diabetes, quality of life, occupational status and education level \u2013 A comparative population-based study","volume":"121","author":"Nielsen","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jcte.2024.100372_b0150","doi-asserted-by":"crossref","DOI":"10.1186\/s12955-020-01370-8","article-title":"The impact of type 1 diabetes on young adults\u2019 health-related quality of life","volume":"18","author":"Bronner","year":"2020","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jcte.2024.100372_b0155","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.healthplace.2013.12.016","article-title":"Why do young adults with Type 1 diabetes find it difficult to manage diabetes in the workplace?","volume":"26","author":"Balfe","year":"2014","journal-title":"Health Place"},{"key":"10.1016\/j.jcte.2024.100372_b0160","first-page":"281","article-title":"The current total economic burden of diabetes mellitus in the Netherlands","volume":"75","author":"Peters","year":"2017","journal-title":"Neth J Med"},{"key":"10.1016\/j.jcte.2024.100372_b0165","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1111\/dom.15105","article-title":"Use of hospital care among Dutch diabetes patients","volume":"25","author":"de Vries","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jcte.2024.100372_b0170","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2864069","article-title":"Direct medical expenditures associated with eye complications among adults with diabetes in the United States","author":"Meraya","year":"2020","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.jcte.2024.100372_b0175","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15326","article-title":"Estimation of the direct health and indirect societal costs of diabetes in the UK using a cost of illness model","author":"Hex","year":"2024","journal-title":"Diabet Med"},{"key":"10.1016\/j.jcte.2024.100372_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.trre.2024.100870","article-title":"Effect of islet alone or islets after kidney transplantation on quality of life in type 1 diabetes: A systematic review","volume":"38","author":"Gariani","year":"2024","journal-title":"Transplant Rev"},{"key":"10.1016\/j.jcte.2024.100372_b0185","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.958671","article-title":"Fear of hypoglycemia and quality of life in young people with type 1 diabetes and their parents in the era of sensor glucose monitoring","volume":"13","author":"Glocker","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jcte.2024.100372_b0190","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jdiacomp.2015.09.003","article-title":"Fear of hypoglycemia in adults with type 1 diabetes: impact of therapeutic advances and strategies for prevention - a review","volume":"30","author":"Martyn-Nemeth","year":"2016","journal-title":"J Diabetes Compl"},{"key":"10.1016\/j.jcte.2024.100372_b0195","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/TP.0b013e31818a7f45","article-title":"Improved long-term health-related quality of life after islet transplantation","volume":"86","author":"Tharavanij","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.jcte.2024.100372_b0200","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1600-6143.2005.01174.x","article-title":"Quality of life after islet transplantation","volume":"6","author":"Poggioli","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jcte.2024.100372_b0205","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.2337\/dc17-1779","article-title":"Improved health-related quality of life in a phase 3 islet transplantation trial in type 1 diabetes complicated by severe hypoglycemia","volume":"41","author":"Foster","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcte.2024.100372_b0210","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2023.11633","article-title":"The relevance of advanced therapy medicinal products in the field of transplantation and the need for academic research access: overcoming bottlenecks and claiming a new time","volume":"36","author":"Piemonti","year":"2023","journal-title":"Transpl Int"},{"year":"2013","series-title":"Principles of biomedical ethics","author":"Beauchamp","key":"10.1016\/j.jcte.2024.100372_b0215"}],"container-title":["Journal of Clinical & Translational Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214623724000437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214623724000437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T23:22:03Z","timestamp":1733959323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214623724000437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":43,"alternative-id":["S2214623724000437"],"URL":"https:\/\/doi.org\/10.1016\/j.jcte.2024.100372","relation":{},"ISSN":["2214-6237"],"issn-type":[{"type":"print","value":"2214-6237"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The bio-artificial pancreas to treat type 1 diabetes: Perspectives from healthcare professionals in the Netherlands","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical & Translational Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcte.2024.100372","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100372"}}